Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

AC-7700 reduces tumor blood flow and inhibits tumor growth in rats

Oct. 4, 2002

New trial of Genasense plus Gleevec in Gleevec-resistant CML patients

Oct. 3, 2002

Optimer acquires license to Globo H vaccine

Oct. 3, 2002

Early phase III enrollment for extended-release Eligard

Oct. 3, 2002

Integrin antagonists covered by 3-Dimensional patent

Oct. 3, 2002

New metal complexes as prodrugs of antitumor compounds

Oct. 3, 2002

Geron receives award for ongoing development of telomerase inhibitors for cancer

Oct. 3, 2002

Benefit:risk ratio of tamoxifen for breast cancer prophylaxis evaluated in large trial

Oct. 3, 2002

Iseganan fails to meet primary endpoint in ulcerative oral mucositis phase III trial

Oct. 2, 2002

Orphan drug grant for Endostatin trial

Oct. 2, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Regulatory actions for July 27, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alfasigma,...